Induction of nitric oxide production in infiltrating leukocytes following in vivo irradiation of tumor-bearing mice

Radiation Oncology Investigations

Volumn 7, Issue 2, 1999, Pages 86-97

  Vodovotz, Yoram ^a,c   Coffin, Deborah ^a   DeLuca, Anne Marie ^a   McKinney, Leslie ^b   Cook, John A ^a   Wink, David ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Armed Forces Hadiobiology Research Institute   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Macrophage; Mouse; Nitric oxide; Radiation; Tumor

Indexed keywords

CD45 ANTIGEN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CANCER TRANSPLANTATION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; IONIZING RADIATION; LEUKOCYTE MIGRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

ANIMALS; CELL CYCLE; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032937731     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:2<86::AID-ROI4>3.0.CO;2-L     Document Type: Article

References (70)

1. Schultz RM, Pavlidis NA, Chirigos MA, et al. Effects of whole body X-irradiation and cyclophosphamide treatment on induction of macrophage tumoricidal function in mice. Cell Immunol 1978;38:302-309.
2. Voevodskaya NV, Vanin AF. Gamma-irradiation potentiates L-arginine-dependent nitric oxide formation in mice. Biochem Biophys Res Commun 1992;186:1423-1428
3. Mikoyan VD, Voevodskaya NV, Kubrina LN, et al. Exogenous iron and g-irradiation induce NO-synthase synthesis in mouse liver. Biochemistry (Moscow) 1994;59:732-738
4. Jeevan A, Bucana CD, Dong Z, et al. Ultraviolet radiation reduces phagocytosis and intracellular killing of mycobacteria and inhibits nitric oxide production by macrophages in mice. J Leukoc Biol 1995;57:883-890.
5. Ibuki Y, Goto R. Augmentation of NO production and cytolytic activity of Mphi obtained from mice irradiated with a low dose of γ-rays. J Radiat Res 1995;36:209-220.
6. McKinney LC, Aquila EM, Coffin D, et al. Ionizing radiation potentiates the induction of nitric oxide synthase by interferon-g and/or lipopolysaccharide in murine macrophage cell lines: Role of tumor necrosis factor-α. J Leukoc Biol 1998;64:459-466.
7. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
8. Xie K, Dong Z, Fidler IJ. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol 1996;59:797-803.
9. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728.
10. Weichselbaum RR, Hallahan DE, Sukhatme V, et al. Biological consequences of gene regulation after ionizing radiation exposure. J Natl Cancer Inst 1991;83: 480-484.
11. Ibuki Y, Goto R. Enhancement of NO production from resident peritoneal macrophages by in vitro γ-irradiation and its relationship to reactive oxygen intermediates. Free Rad Biol Med 1997;22:1029-1035.
12. Mantovani A, Bottazzi B, Colotta F, et al. The origin and function of tumor-associated macrophages. Immunology Today 1992;13:265-270.
13. Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 1992;107:1092-1095.
14. Thomsen LL, Lawton FG, Knowles RG, et al. Nitric oxide activity in human gynecological cancer. Cancer Res 1994;54:1352-1354.
15. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-44.
16. Rosbe KW, Prazma J, Petrusz P, et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995;113:541-549.
17. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-4396.
18. Ellie E, Loiseau H, Lafond F, et al. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. NeuroReport 1995;7:294-296.
19. Whittle IR, Collins F, Kelly PAT, et al. Nitric oxide synthase is expressed in experimental malignant glioma and influences tumor blood flow. Acta Neurochir 1996; 138:870-876.
20. Robertson FM, Long BW, Tober KL, et al. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis 1996;17:2053-2059.
21. Doi K, Akaike T, Horie H, et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996;77:1598-1604.
22. Kim JH, Alfieri AA, Kim SH, et al. Radiosensitization of two murine fibrosarcomas with 6-thioguanine. Int J Radiation Oncology Biol Phys 1990;18:583-586.
23. Hahn SM, Sullivan FJ, DeLuca AM, et al. Evaluation of tempol radioprotection in a murine tumor model. Free Rad Biol Med 1997;22:1211-1216.
24. Ding A, Nathan CF, Graycar J, et al. Macrophage deactivating factor and transforming growth factors-β1, -β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-τ. J Immunol 1990;145:940-944.
25. Vodovotz Y, Bogdan C, Paik J, et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J Exp Med 1993;178: 605-613.
26. Sparrow J, Nathan C, Vodovotz Y. Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture. Exp Eye Res 1994;59:129-139.
27. Vodovotz Y. A modified assay for serum nitrite and nitrate. BioTechniques 1996;20:390-394.
28. Vodovotz Y, Geiser AG, Chesler L, et al. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor-β1 null mouse. J Exp Med 1996;183:2337-2342.
29. Dubinett SM, Patrone L, Tobias J, et al. Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo. Cancer Immunol Immunother 1993;36:156-162.
30. Cox GW, Melillo G, Chattopadhyay U, et al. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-τ plus IL-2-induced murine macrophage tumoricidal activity. J Immunol 1992;149:3290-3296.
31. Hibbs JB, Jr., Taintor RR, Vavrin Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987;235:473-476.
32. Drapier J, Hibbs JB, Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988;140:2829-2838.
33. Stuehr DJ, Nathan CF. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169:1543-1555.
34. Thomsen LL, Ching LM, Baguley BC. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid. Cancer Res 1990;50: 6966-6970.
35. Manthey CL, Perera P, Salkowski CA, et al. Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 1994;152:825-831.
36. Son K, Kim Y. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Cancer Res 1995;55:5524-5527.
37. Wink DA, Hanbauer I, Grisham MB, et al. The chemical biology of NO. Insights into regulation, protective and toxic mechanisms of nitric oxide. Curr Top Cell Biol 1996;34:159-187.
38. Wink DA, Cook JA, Christodoulou D, et al. Nitric oxide (NO) and some NO donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide: Biol and Chem 1997;1:88-94.
39. Wood PJ, Stratford IJ, Adams GE, et al. Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem Biophys Res Commun 1993;192:505-510
40. Mitchell JB, Wink DA, DeGraff W, et al. Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res 1993;53:5845-5848.
41. Pipili-Synetos E, Papageorgiou A, Sakkoula E, et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995;116:1829-1834.
42. Hibbs JJB, Westenfelder C, Taintor R, et al. Evidence for cytokine-inducible nitric oxide synthesis from L- Arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992;89:867-877.
43. Umansky V, Rocha M, Krüger A, et al. In situ activated macrophages are involved in host resistance to lymphoma metastasis by production of nitric oxide. Int J Oncol 1995;7:33-10.
44. Ochoa JB, Curti B, Peitzman AB, et al. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst 1992;84:864-867.
45. Farias-Eisner R, Sherman MP, Aeberhard E, et al. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 1994;91:9407-9411.
46. Miles D, Thomsen L, Balkwill F, et al. Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Inv 1994;24:287-290.
47. Yu W, Ogawa M, Mu J, et al. IL-12-induced tumor regression correlates with in situ activity of IFN-g produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways. J Leukoc Biol 1997; 62:450-457.
48. Moochhala S, Chhatwal VJ, Chan ST, et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171-1174.
49. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-1003.
50. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996;313: 17-29.
51. Buttery LDK, Springall DR, Andrade SP, et al. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J Pathol 1993;171:311-319.
52. Arias-Diaz J, Vara E, Torres-Melero J, et al. Nitrite/ nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer 1994;74:1546-1551.
53. Edwards P, Cendan JC, Topping DB, et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996;63:49-52.
54. Albina JE, Mills CD, Henry WL, et al. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990;144:3877-3880.
55. Smith DJ, Dunphy MJ, Strag LN, et al. The influence of wound healing on urinary nitrate levels in rats. Wounds 1991;3:50-58.
56. Carter EA, DeRojas-Walker T, Tamir S, et al. Nitric oxide production in intensely and persistently increased in tissue by thermal injury. Biochem J 1994;304:201-204.
57. Preiser J, Reper P, Vlasselaer D, et al. Nitric oxide production is increased in patients after bum injury. J Trauma 199640:368-371.
58. Schaffer MR, Tantry U, Gross SS, et al. Nitric oxide regulates wound-healing. J Surg Res 1996;63:237-240.
59. Lambert LE, Paulnock DM. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway. J Immunol 1987;139: 2834.
60. Sanchez-Bueno A, Verkhusha V, Tanaka Y, et al. Interferon-g-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-g-inducing factor in macrophages elicited by allografted tumor cells. Biochem Biophys Res Commun 1996;224:555-563.
61. Stevenson AP, Crissman HA, Stewart CC. Macrophage-induced cytostasis: Kinetic analysis of bromodeoxyuridine-pulsed cells. Cytometry 1985;6:578-583.
62. Sariban E, Imamura K, Luebbers R, et al. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988;81:1506-1510.
63. Hallahan DE, Spriggs DR, Beckett MA, et al. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 1989;86:10104-10107.
64. Sherman ML, Datta R, Hallahan DE, et al. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 1991;87:1794-1797.
65. Vodovotz Y. Control of nitric oxide production by transforming growth factor-β1: Mechanistic insights and potential relevance to human disease. Nitric Oxide: Biol and Chem 1997;1:3-17.
66. Barcellos-Hoff MH. Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 1993;53:3880-3886.
67. Barcellos-Hoff MH, Derynck R, Tsang ML, et al. Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-899.
68. Wahl SM. Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 1994;180:1587-1590.
69. Espevik T, Figari IS, Shalaby MR, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987;166:571-576.
70. Bogdan C, Paik J, Vodovotz Y, et al. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 1992;267:23301-23308.